A comparative study of antibody titers of blister fluid and serum in patients with subepidermal immunobullous diseases

International Journal of Dermatology

Volumn 43, Issue 5, 2004, Pages 348-351

  Daneshpazhooh, Maryam ^a   Shahdi, Majid ^a   Aghaeepoor, Mahnaz ^a   Hasiri, Gholamreza ^a   Chams, Cheida ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; SODIUM CHLORIDE;

ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; BLISTER; BLOOD ANALYSIS; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; MALE; PEMPHIGOID GESTATIONIS; SENSITIVITY ANALYSIS; SKIN DISEASE; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; SKIN DISEASES, VESICULOBULLOUS;

EID: 2642587587     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.01902.x     Document Type: Article

References (14)

1. Diaz LA, Giudice GJ. End of the century overview of skin blisters. Arch Dermatol 2000; 136: 106-112.
2. Ameglio F, D'Auria L, Bonifati C, et al. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity. Br J Dermatol 1998; 138: 611-614.
3. Bhol KC, Rojas AI, Khan IU, et al. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Cytokine 2000; 12: 1076-1083.
4. Sun CC, Wu J, Wong TT, et al. High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T-cell activities. Br J Dermatol 2000; 143: 1235-1240.
5. Bean SF. Blister fluid in pemphigus. J Invest Dermatol 1969; 53: 187.
6. Bean SF. Blister fluid in bullous pemphigoid. Acta Dermatovenereol (Stockholm) 1970; 50: 95-96.
7. Zhou S, Wakelin SH, Allen J, et al. Blister fluid for diagnosis of subepidermal immunobullous diseases: a comparative study of basement membrane zone autoantibodies detected in blister fluid and serum. Br J Dermatol 1998; 139: 27-32.
8. Kelly SE, Wojnarowska F. The use of chemically split tissue in detection of circulating antibasement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 1988; 118: 31-40.
9. Gammon WR, Briggaman RA, Inman AO, et al. Differentiating anti-lamina lucida and anti-sublamina densa anti BMZ antibodies by IIF on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984; 82: 139-144.
10. Kanitakis J, Vassileva S, Woodley D, eds. Diagnostic Immunohistochemistry of the Skin, 1st edn. London: Chapman & Hall, 1998: 5-9.
11. Zhu XJ, Niimi Y, Bystryn JC. Epidermolysis bullosa acquisita: incidence in patients with basement membrane zone antibodies. Arch Dermatol 1990; 126: 171-174.
12. Ghohestani R, Kanitakis J, Nicolas JF, et al. Comparative sensitivity of indirect immunofluorescence to immunoblot assay for detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol 1996; 135: 74-79.
13. Onodera Y, Shimizu H, Hashimoto T, et al. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin. J Invest Dermatol 1994; 102: 685-960 [Abstract].
14. Kirtschig G, Wojnarowska F. IgA basement membrane zone autoantibodies in bullous pemphigoid detect epidermal antigens oOf 270-280 kDa, 230 kDa, and 180 kDa molecular weight by immunoblotting. Clin Exp Dermatol 1999; 24: 302-307.